Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes

A speculative synthesis

Mary Stenzel-Poore, Susan L. Stevens, Jeffrey S. King, Roger P. Simon

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.

Original languageEnglish (US)
Pages (from-to)680-685
Number of pages6
JournalStroke
Volume38
Issue number2 PART 2
DOIs
StatePublished - Feb 2007

Fingerprint

Phenotype
Wounds and Injuries
Ischemia
Endotoxins
Lipopolysaccharides
Neuroprotection
Brain
Therapeutics

Keywords

  • Genomics
  • Neuroprotectants
  • Preconditioning
  • Stroke
  • Toll-like receptors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes : A speculative synthesis. / Stenzel-Poore, Mary; Stevens, Susan L.; King, Jeffrey S.; Simon, Roger P.

In: Stroke, Vol. 38, No. 2 PART 2, 02.2007, p. 680-685.

Research output: Contribution to journalArticle

@article{1308cc9699f84b1499de989848a0de92,
title = "Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: A speculative synthesis",
abstract = "Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.",
keywords = "Genomics, Neuroprotectants, Preconditioning, Stroke, Toll-like receptors",
author = "Mary Stenzel-Poore and Stevens, {Susan L.} and King, {Jeffrey S.} and Simon, {Roger P.}",
year = "2007",
month = "2",
doi = "10.1161/01.STR.0000251444.56487.4c",
language = "English (US)",
volume = "38",
pages = "680--685",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "2 PART 2",

}

TY - JOUR

T1 - Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes

T2 - A speculative synthesis

AU - Stenzel-Poore, Mary

AU - Stevens, Susan L.

AU - King, Jeffrey S.

AU - Simon, Roger P.

PY - 2007/2

Y1 - 2007/2

N2 - Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.

AB - Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.

KW - Genomics

KW - Neuroprotectants

KW - Preconditioning

KW - Stroke

KW - Toll-like receptors

UR - http://www.scopus.com/inward/record.url?scp=33846635975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846635975&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000251444.56487.4c

DO - 10.1161/01.STR.0000251444.56487.4c

M3 - Article

VL - 38

SP - 680

EP - 685

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 2 PART 2

ER -